Cinda Biotech (01801.HK) grants 3,371 share options and 9551 restricted shares

Gelonghui, May 3, 丨 Cinda Biotech (01801.HK) announced that on May 3, 2024, the company granted 3,371 share purchase rights to independent non-executive director Chen Shuyun in accordance with the terms of the initial public offering after-sales employee share ownership plan, subject to Chen's acceptance. The board of directors announced that on May 3, 2024, the company granted 9551 restricted shares to Chen Shuyun in accordance with the 2020 Restricted Shares Plan, subject to Chen's acceptance and approval by independent shareholders at the Annual General Meeting of Shareholders.

Gelonghui FinanceMay 3 22:40

Cinda Biotech (01801): Zhang Qian was appointed as Executive Director and Strategy Committee Member

Cinda Biotech (01801) announced that since May 3, 2024, Mr. Chen Shuyun has been appointed as an independent non-...

Zhitong FinanceMay 3 22:24

CSPC Group (01093.HK) cancelled 26.628 million shares on May 3

Gelonghui, May 3, 丨 Shiyao Group (01093.HK) announced that on May 3, 2024, 26.628 million shares have been cancelled.

Gelonghui FinanceMay 3 16:33

Express News | Hong Kong stocks generally fell by “Pharmacology”. Pharmacovigilance fell by more than 10%. At one point, Yao Ming Biotech and Pharmaceutical Kangde fell by more than 7%.

BreakingsMay 3 15:51

CCB International: Maintaining Cinda Biotech's (01801) “Outperform the Market” rating and raising the target price to HK$54.7

According to CCB International, Cinda Biotech (01801) is one of the bank's preferred stocks in the Chinese pharmaceutical industry.

Zhitong FinanceMay 3 13:39

Cinda Biotech (1801.HK): Strong revenue growth in the first quarter, various products will be unveiled at the ASCO conference

Core view The company's revenue for the first quarter of 2024 exceeded 1.7 billion yuan, a strong year-on-year increase of more than 60%. At the same time, sales continued to grow month-on-month under the influence of the 24Q1 Spring Festival. Sales exceeded 1.6 billion yuan in the fourth quarter of '23, and performance performance

中信建投證券May 3 00:00